Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer

BACKGROUND: Histone lysine lactylation (Kla) is a newly identified histone modification, which plays a crucial role in cancer progression. Hence, we determined the prognostic value of Kla in breast cancer (BC). METHODS: We obtained RNA expression profiles of BC from The Cancer Genome Atlas (TCGA), f...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jian, Liao, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636881/
https://www.ncbi.nlm.nih.gov/pubmed/37950222
http://dx.doi.org/10.1186/s12920-023-01726-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636881/
https://www.ncbi.nlm.nih.gov/pubmed/37950222
http://dx.doi.org/10.1186/s12920-023-01726-1

Ejemplares similares